Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Barrington Research Reaffirms Bullish Outlook on ICF International Raises Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Barrington Research reaffirms its bullish outlook on ICF International (NASDAQ: ICFI) on March 4, 2024, raising its price target to $173.00 from $145.00. This adjustment reflects an 11.02% increase from the current share price of $155.83. Analysts collectively view ICF International as a Moderate Buy, with an average price target of $177.50 based on 2 buy ratings. Over the last 3 months, ICFI has garnered 4 Buy Ratings, signaling strong investor confidence in the company’s future performance.

ICF International, Inc. (ICFI) Stock Sees Positive Performance, Indicates Investor Confidence for Future Growth

On March 4, 2024, ICF International, Inc. (ICFI) saw a positive performance in the stock market. The price of ICFI shares increased by $0.93 since the previous market close, representing a 0.60% rise. Despite opening lower at $155.38, the stock climbed throughout the day, indicating investor confidence. ICFI is a global consulting and technology services company known for delivering innovative solutions and driving growth. The positive price momentum and stock trading near its 52-week high suggest further upside potential. Investors should conduct thorough research before making investment decisions.

ICF International (ICFI) Stock Performance Analysis: Positive Growth in Revenue, Net Income, and EPS

On March 4, 2024, ICF International (ICFI) stock had a mixed performance based on the latest financial data provided by CNN Money. The company reported total revenue of $1.96 billion for the past year, with a quarterly revenue of $478.35 million. This represents a 10.3% increase in total revenue since the previous year, but total revenue remained flat compared to the last quarter.

In terms of net income, ICF International reported a net income of $82.61 million for the past year, with a quarterly net income of $22.16 million. Net income increased by 28.59% since the previous year, but like total revenue, it held flat compared to the last quarter.

Earnings per share (EPS) for ICF International were reported at $4.35 for the past year, with a quarterly EPS of $1.16. EPS increased by 28.86% since the previous year, but like total revenue and net income, it remained flat compared to the last quarter.

Overall, the financial performance of ICF International on March 4, 2024, showed positive growth in terms of total revenue, net income, and EPS compared to the previous year. However, the company’s performance held flat compared to the last quarter, indicating a stable but not necessarily improving trend.

Investors and analysts may be interested in monitoring future financial reports from ICF International to see if the company can sustain its growth trajectory and potentially improve its performance in the upcoming quarters. As with any investment, it is important to conduct thorough research and analysis before making any decisions regarding ICF International stock.

Tags: ICFI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance analyst

Anticipating Angel Oak Mortgage REITs Quarterly Earnings March 5 2024

Biotechnology Stock Bull Market

Neurogenes Breakthrough in Rett Syndrome Gene Therapy Trial Expansion and Accelerated Enrollment Plans

financial-data

Full House Resorts NASDAQFLL Quarterly Earnings Preview and Historical Performance

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com